Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 364.00
Bid: 363.00
Ask: 364.00
Change: -0.50 (-0.14%)
Spread: 1.00 (0.275%)
Open: 367.50
High: 367.50
Low: 361.50
Prev. Close: 364.50
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Jan 2010 07:00

RNS Number : 2279F
Lupus Capital PLC
08 January 2010
 



Lupus Capital plc

("Lupus" or the "Company")

Directorate Change

Lupus Capital plc announces that Non-Executive directors Michael Jackson and Roland Tate have decided it is an appropriate time for them to retire from their positions on the Board. Their retirements will take effect from 31 January 2010. They have agreed to remain available to the Company for a short period of time thereafter, to ensure a smooth handover of responsibilities. The Company would like to thank Mr Jackson and Mr Tate for their valued contributions to Lupus throughout their tenures.

Michael Jackson commented:

"Following the recent appointments at Chairman and Non-Executive Director level, I feel it is an appropriate time for me to step aside and allow the newly strengthened Board to focus on positioning the Company to take full advantage of the economic recovery and create further value for shareholders."

Roland Tate commented:

"After seven years as a Non-Executive Director of Lupus I have decided that the time is right for me to stand down from the Board.  I am pleased to have played a key role in securing the Company's refinancing in 2009 and the subsequent recruitment of the new Non-Executive team.  I leave the Company with a stable foundation for future growth and wish the new team and Lupus well for the future."

Jamie Pike, Non-Executive Chairman, commented:

"I would like to thank Michael and Roland for their enormous personal contributions to Lupus over what has been a period of very significant distraction for the business and wish them both well for the future."

Enquiries

Collins Stewart Europe Limited  Tel: +44 (0)20 7523 8350

Mark Dickenson / Tom Hulme

College Hill Tel: +44 (0)20 7457 2020

Mark Garraway / Gareth David

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVDLFBBFFFBBK
Date   Source Headline
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.